13F-HR filed by Camber Capital Management LP
Camber Capital Management LP filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 28 holding rows worth $2,006,982,000.
- Accession
- 0001654954-19-006002
- Filer
- CIK 1444043
- Filed
- 2019-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2019
A holdings report, 28 entries on the cover page, a total value of $2,006,982,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,006,982,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 1,000,000 | $282,480,000 | thousands by filing date | put |
| ALLERGAN PLC | G0177J108 | SHS | 1,300,000 | $190,333,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 5,750,000 | $162,955,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 2,100,000 | $101,136,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 1,800,000 | $95,274,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 400,000 | $94,552,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 650,000 | $86,951,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 1,500,000 | $81,435,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 600,000 | $81,108,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 2,000,000 | $79,500,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 11,000,000 | $72,380,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 2,471,523 | $69,079,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 2,000,000 | $67,200,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 500,000 | $59,595,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 4,000,000 | $58,120,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 3,500,000 | $54,880,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 1,100,000 | $52,481,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 430,000 | $50,611,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 1,750,000 | $50,470,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 750,000 | $42,593,000 | thousands by filing date | |
| SYNTHORX INC COM | 87167A103 | Stock | 1,862,116 | $37,931,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 1,500,000 | $37,230,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 2,166,000 | $35,046,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 2,650,000 | $34,132,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 291,600 | $14,723,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 600,000 | $6,834,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 930,001 | $6,147,000 | thousands by filing date | |
| SURGERY PARTNERS INC | 86881A100 | COM | 160,084 | $1,806,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001654954-19-006002 | this filing | 2019-05-15 | acceptance time not in the bulk data set |